Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control

This publication has 53 references indexed in Scilit:

• PIN13 ANNUAL COST FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN THE UNITED STATES
  Value in Health, 2005
• Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital
  European Journal of Clinical Microbiology & Infectious Diseases, 2004
• Additional Costs for Preventing the Spread of Methicillin-Resistant Staphylococcus aureus and a Strategy for Reducing These Costs on a Surgical Ward
  Infection Control & Hospital Epidemiology, 2003
• Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
  Journal of Antimicrobial Chemotherapy, 2003
• Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis
  Clinical Infectious Diseases, 2003
• Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year Survey
  European Journal of Clinical Microbiology & Infectious Diseases, 2002
• The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
  Emerging Infectious Diseases, 1999
• Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
  Infection Control & Hospital Epidemiology, 1997
• Long-term efficacy of a program to control methicillin-resistantStaphylococcus aureus
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Control of methicillin-resistantStaphylococcus aureus bacteraemia in high-risk areas
  European Journal of Clinical Microbiology & Infectious Diseases, 1994